Skip to content
CALL: (800) 884-9600

Lupus and Social Security Disability Benefits

Listing 14.02, organ involvement, flares, and combined limitations

Last Updated September 17, 2026

Conditions Center · Immune System · Social Security Disability

Also called systemic lupus erythematosus (SLE).

Lupus may qualify for SSDI or SSI when organ involvement, fatigue, pain, cognitive effects, treatment, or flares prevent sustained work. Because lupus can shift between flare and remission and can affect different systems, SSA needs a longitudinal record. A positive blood test establishes neither the full diagnosis nor listing-level severity by itself.

What is Lupus?

Systemic lupus erythematosus is a chronic autoimmune disease in which the immune system attacks the body’s own tissues. It can cause inflammation and damage in the joints, skin, kidneys, heart, lungs, blood cells, or brain. Symptoms and severity vary, and periods of flare may alternate with periods of relative remission.

Common symptoms of Lupus

  • Fatigue, fever, or malaise during active disease
  • Painful, stiff, or swollen joints
  • Skin rashes or sensitivity to sunlight
  • Chest pain with inflammation around the heart or lungs
  • Kidney, blood-cell, or neurologic symptoms in some people

How can Lupus affect a person’s ability to work?

  • Variable stamina and reduced persistence during flares
  • Limited standing, walking, lifting, or hand use from joint inflammation
  • Need to avoid intense sun exposure when photosensitivity is documented
  • Cognitive or concentration difficulty when medically supported
  • Absences for flares, infusions, laboratory monitoring, or organ complications

Does Social Security have a Listing for Lupus?

Social Security currently has listing criteria that may apply: 14.02 (Systemic lupus erythematosus). Meeting a listing requires the specific medical findings in that listing, not only the diagnosis.

Listing 14.02 has more than one pathway. A lupus diagnosis or positive ANA alone is not enough; the record must show the required organ or body-system involvement, or repeated manifestations with the constitutional symptoms and functional limitation described in the listing.

SSA evaluates systemic lupus under Listing 14.02 using medical history, examination, laboratory findings, treatment, and the pattern of manifestations over time. One pathway requires qualifying involvement of two or more organs or body systems; another addresses repeated manifestations with constitutional symptoms and marked functional limitation. If the listing is not met, SSA considers the combined physical and mental effects in RFC.

Can you qualify if you do not meet an SSA Listing?

Yes. If lupus does not meet Listing 14.02, SSA still considers the combined physical and mental effects of medically supported organ involvement, fatigue, pain, flares, and treatment in the residual functional capacity assessment. SSA then uses that RFC at the later steps of the evaluation to determine whether past relevant work or other work remains possible.

What medical evidence may help document Lupus?

  • Longitudinal rheumatology records identifying manifestations and flares
  • Specialist records for kidney, lung, heart, blood, skin, or neurologic involvement
  • Laboratory trends interpreted by treating clinicians
  • Medication, infusion, and adverse-effect records
  • Functional observations during both flares and more stable periods

Testing, imaging, and laboratory studies

  • ANA and more specific antibody testing interpreted in clinical context
  • CBC, kidney function, urinalysis, complement, and inflammatory markers as ordered
  • Biopsy, imaging, or organ-specific testing when medically indicated

Treatment intensity and side effects may vary with disease activity. The record should explain steroid effects, infection risk, infusion schedules, and reasons for medication changes rather than treating a medication name as proof of severity.

How SSA may evaluate residual functional capacity

Lupus RFC should combine limitations across systems. Individually modest joint, fatigue, kidney, and concentration problems may together make full-time work unsustainable, particularly when flares or treatment cause repeated absence.

Physical limits may involve lifting, standing, walking, handling, environmental exposure, or sun avoidance depending on the organs and joints involved.

Concentration, memory, or adaptation limitations should be included when supported by the medical evidence and longitudinal record. A separate neurological or psychiatric diagnosis is not automatically required when the functional effects stem from medically established lupus.

Common issues that can weaken a disability claim involving Lupus

Relying on ANA alone; vague references to “lupus flares” without dates or findings; or failing to obtain records from specialists treating organ involvement.

What may strengthen the medical documentation

A flare timeline, organ-by-organ evidence, medication effects, and consistent functional observations show the full disease pattern better than a single rheumatology visit.

Lupus and related medical conditions

  • Blood Disorders — Adult Listing 7.00 addresses nonmalignant hematological disorders, including hemolytic anemias, disorders of thrombosis and hemostasis, bone marrow failure, hematological transplantation, and repeated complications. Malignant blood cancers are generally evaluated under Listing 13.00, with specified HIV-associated lymphomas evaluated under Listing 14.11.
  • Chronic Kidney Disease — Current Listing 6.00 includes separate pathways for ongoing dialysis, kidney transplant, impaired kidney function with complications, and repeated CKD hospitalizations.
  • Fibromyalgia — A medically determinable impairment under SSR 12-2p when diagnostic criteria are documented. There is no fibromyalgia listing.
  • Inflammatory Arthritis — A broad group of immune-mediated joint and spine diseases, including psoriatic arthritis and ankylosing spondylitis. Listing 14.09 has several disease-pattern pathways.
  • Interstitial Cystitis — Interstitial cystitis has no dedicated SSA listing. SSR 15-1p explains how SSA establishes interstitial cystitis as a medically determinable impairment and considers medical equivalence or residual functional capacity based on the documented pain, urinary frequency or urgency, sleep disruption, treatment, and other functional effects.
  • Peripheral Neuropathy — Damage to peripheral nerves that may cause pain, numbness, weakness, or balance problems. Listing 11.14 applies only when its specified functional criteria are met.
  • Rheumatoid Arthritis — An inflammatory autoimmune arthritis. SSA may evaluate it under Listing 14.09 when the current immune-system criteria are met.

How Brock & Stout may help

We can organize the record by the Listing 14.02 pathways, seek missing specialist and infusion evidence, and present combined limitations in RFC when no single manifestation meets the listing.

Frequently asked questions

Related Brock & Stout resources

Speak with a Social Security Disability attorney

If Lupus is affecting your ability to work, Brock & Stout can review the claim, look for missing medical evidence, and discuss next steps. If we represent you, you do not owe attorney fees or case costs if the claim is denied.

Prefer to send us your information? Request a case evaluation.

This page is general educational information about Social Security Disability as of the date of this publication. It is not legal or medical advice, does not create an attorney-client relationship, and does not guarantee results. Eligibility depends on individual facts and current Social Security rules.